Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.17 USD | +6.01% | +8.52% | -0.33% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 618M |
---|---|---|---|---|---|
Net income 2024 * | -114M | Net income 2025 * | -139M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.33
x | P/E ratio 2025 * |
-4.75
x | Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.45% |
Latest transcript on ORIC Pharmaceuticals, Inc.
1 day | +6.01% | ||
1 week | +8.52% | ||
Current month | +2.00% | ||
1 month | -5.56% | ||
3 months | -40.80% | ||
6 months | +3.38% | ||
Current year | -0.33% |
Managers | Title | Age | Since |
---|---|---|---|
Jacob Chacko
CEO | Chief Executive Officer | 45 | 18-05-06 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Director of Finance/CFO | 50 | 19-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Angie You
BRD | Director/Board Member | 51 | 21-11-08 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Mardi Dier
BRD | Director/Board Member | 60 | 20-03-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.48% | 4 M€ | -5.15% | - | |
0.03% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 9.17 | +5.89% | 520,382 |
24-06-04 | 8.66 | -1.37% | 350,834 |
24-06-03 | 8.78 | -2.34% | 446,638 |
24-05-31 | 8.99 | +0.67% | 973,865 |
24-05-30 | 8.93 | +5.68% | 457,108 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.33% | 618M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+4.75% | 22.67B | |
-9.70% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- ORIC Stock